I have been a strong advocate of electronic medical records (EMRs) for almost a decade. In fact, I used the phrases “It is the silver bullet for health care reform infrastructure” and “It is the cornerstone for health care reform infrastructure” to describe EMR plans when President Obama was campaigning. However, technology, like fire, can warm your house or burn it down, cook your food or kill you. Likewise, the wrong EMR will escalate inefficiency and raise health care costs. The wrong mandates or the wrong incentives have the potential to paralyze the day-to-day practice of medicine.
Scarless Surgery: The benefits and drawbacks of robotic thryroidectomy
Using robotic arms, surgeons can now remove the thyroid gland through an incision in the axilla, or armpit, thereby avoiding the large scar on the front of the neck caused by traditional thyroid surgery. The procedure offers no other benefits over the traditional approach developed a century ago by Emil Theodor Kocher, MD, according to head and neck surgeons who perform the robotic surgery. In fact, it takes longer to recover from the robotic surgery, they say, with some patients complaining of chest numbness for months afterwards.
The Future of Genomics Is Now: Dr. Thomas C. Spelsberg discusses the clinical implications
The genome project sequenced all three billion base pairs of human DNA, revealing the instructions cells need to build all the proteins in the body. But that was just a warm-up, according to Thomas C. Spelsberg, PhD, of the Mayo Clinic in Rochester, Minn.
HIPAA Expansion: Ensure your practice meets the law’s new provisions
On Feb. 17, 2009, President Obama signed into law the American Recovery and Reinvestment Act of 2009 (commonly referred to as ARRA or the Stimulus Bill) which includes the Health Information Technology for Economic and Clinical Health (HITECH) Act. The HITECH Act includes significant changes to the Health Insurance Portability and Accountability Act of 1996 (HIPAA) that affect otolaryngologists and other health care providers, as well as those who process or work with health care information. Below is a summary of how these new provisions, many of which go into effect this Feb. 17, will affect your practice.
Fill the Gap: Strategies for addressing the otolaryngology workforce shortage
How do you plan to deal with workforce shortages? If you are like 55 percent of the audience at an interactive mini-seminar held during the October American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) Foundation annual meeting, you intend to hire additional otolaryngologists to help with practice overload.
Product Watch
Each month, Product Watch offers readers the latest information on new and innovative products for otolaryngologists-head and neck surgeons.
Hearing Aid Update
Hearing aids-external electronic devices used to help individuals with hearing loss-traditionally consist of a microphone, an analog-to-digital converter, a digital signal processor, a digital-to-analog converter, and a receiver that delivers an acoustic signal into the external auditory canal. In 2008, 97% of all hearing aids sold used digital processing. Catherine V. Palmer, PhD, provides a review of current digital hearing aids.
Universal Electronic Health Records: Progress or Boondoggle?
Implementing electronic health records (EHRs) for all 633,000 physicians and 5708 hospitals in the United States is a daunting task, and one that is being nudged forward by Team Obama’s $19 billion stimulus plan earmarked to help health care providers to switch to EHRs.
Narrow-Band Imaging Helps Diagnose Barrett’s Esophagus, Study Shows
Patients who undergo a transnasal esophagoscopy using narrow-band imaging are more likely to have dysplasia diagnosed with a biopsy than those who have the exam using only white light, researchers have reported.
Cellular Therapy of Autoimmune Disease
Cellular therapy refers to the use of live cells to replace or repair a damaged organ system. The first widespread use of this approach occurred more than 50 years ago when hematopoietic stem cells (HSCs) from the bone marrow of a healthy donor (allogeneic) were used to replace the hematopoietic system of a recipient after it was ablated during chemo/radio therapy of leukemia, the recipient’s hematopoietic system being “collateral damage” during the eradication of the unwanted leukemia cells.
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 11
- Next Page »